• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    BioCity To Present SC0062 Data At ASN 2024 And In JASN

    PR NEWSWIRE

    BioCity`s Granted BTD By NMPA For IgA Nephropathy with Proteinuria

    PR NEWSWIRE

    BioCity Reports BC3195 Interim Results At ESMO 2024

    PR NEWSWIRE

    BioCity`s SC0062 Meets Primary Endpoint In Phase 2 IgA Nephropathy Trial

    PR NEWSWIRE

    BioCity Gets IND Clearance For Glypican 3 ADC

    PR NEWSWIRE

    BioCity Announces Enrollment Completion of the IgAN Cohort in SC0062

    PR NEWSWIRE

    BioCity announces first patient dosed with anti-TIM-3 mAb BC3402 with IMFINZI

    PR NEWSWIRE

    BioCity Signs Collaboration Agreement with AstraZeneca on BC3402

    PR NEWSWIRE

    BioCity announces FDA clearance of Investigational NDA for CD3/EGFR antibody

    PR NEWSWIRE

    BioCity announces the first patient dosed with ADC BC3195 in a Phase 1 Trial

    PR NEWSWIRE

    BioCity Announces Initiation of a Phase 2 Trial for SC0062,

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.